Nailing Zhang

3PUBLICATIONS
41CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 27, 2025
FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Treatment of Patients with Unresectable or Metastatic, HR-Positive, HER2-Negative Breast Cancer.

Melanie Royce, Mirat Shah, Lijun Zhang

|Jun 28, 2018
Characterization of a cdc14 null allele in Drosophila melanogaster.

Leif R Neitzel, Matthew R Broadus, Nailing Zhang

|Feb 01, 2017
Merlin controls the repair capacity of Schwann cells after injury by regulating Hippo/YAP activity.

Thomas Mindos, Xin-Peng Dun, Katherine North

Pageof 1